Equibles does not estimate personal net worth.
Kevin Moran is recorded as CFO at Vanda Pharmaceuticals Inc. (VNDA). The newest filing on record that lists Kevin Moran as CFO at Vanda Pharmaceuticals Inc. (VNDA) is dated April 23, 2026. The proxy statement of Vanda Pharmaceuticals Inc. reports total compensation of $1,439,660 for Kevin Moran in fiscal 2025, including a base salary of $559,935. Disclosed compensation is on record for 6 fiscal years. Kevin Moran has spoken on 25 earnings calls and 2 other investor events across 1 company, most recently for Vanda Pharmaceuticals Inc. on September 15, 2026. Vanda Pharmaceuticals Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vanda Pharmaceuticals Inc. includes Mihael Polymeropoulos (CEO and Board Member), Anne Sempowski Ward (Board Member), Charles C. Duncan (Board Member) and 5 others.
“Could you give us a brief introduction going into, you know, for those who are still trying to get familiar with vonda uh could you give a simple snapshot of the company today and how the portfolio has broadened overall yeah perfect and first off i'd like to say thank you jan and the hcw team for having us here thank…”
“Good afternoon, and thank you for joining us to discuss Vanda Pharmaceutical's second quarter 2026 performance.”
“Yeah, so starting first with the LAI, so as Ram mentioned there, we're in the process of running a phase three study for the FNAP long-acting injectable in schizophrenia.”
“Good afternoon, and thank you for joining us to discuss Vanda Pharmaceutical's first quarter 2026 performance.”
“Good afternoon, and thank you for joining us to discuss Vanda Pharmaceutical's fourth quarter and full year 2025 performance.”
Start not stated–present
Last confirmed April 23, 2026
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Vanda Pharmaceuticals Inc. (VNDA) | Senior Vice President, Chief Financial Officer and Treasurer | $559,935 | $1,439,660 |
| 2024 | Vanda Pharmaceuticals Inc. (VNDA) | Senior Vice President, Chief Financial Officer and Treasurer | $541,000 | $1,447,627 |
| 2023 | Vanda Pharmaceuticals Inc. (VNDA) | Senior Vice President, Chief Financial Officer and Treasurer | $477,000 | $1,324,684 |
| 2022 | Vanda Pharmaceuticals Inc. (VNDA) | Senior Vice President, Chief Financial Officer and Treasurer | $426,120 | $1,440,701 |
| 2021 | Vanda Pharmaceuticals Inc. (VNDA) | Senior Vice President, Chief Financial Officer and Treasurer | $402,000 | $1,971,966 |
| 2020 | Vanda Pharmaceuticals Inc. (VNDA) | Senior Vice President, Chief Financial Officer and Treasurer | $324,693 | $1,319,699 |
